APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Contract Development and Manufacturing Organization

A pharmaceutical CDMO provides contracted drug-development and manufacturing services, including process development, analytical work and production of drug substances or finished dosage forms.

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Contract Development and Manufacturing Organization Market Analysis and Forecast 2026-2032

1 January 2026204 pages

Choose your research edition.

Industry ResearchPharmaceutical Contract Development and Manufacturing Organization Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Contract Development and Manufacturing Organization Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Contract Development and Manufacturing Organization Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Contract Development and Manufacturing Organization Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Contract Development and Manufacturing Organization Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Pharmaceutical Contract Development and Manufacturing Organization market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical Contract Development and Manufacturing Organization is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Contract Development and Manufacturing Organization is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Contract Development and Manufacturing Organization is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Contract Development and Manufacturing Organization is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical Contract Development and Manufacturing Organization include Catalent, Recipharm, Jubilant Life Sciences, Patheon Inc., Boehringer Ingelheim, Pfizer Centreone, Aenova Group, Famar and Baxter Pharmaceutical Solutions, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical Contract Development and Manufacturing Organization, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Contract Development and Manufacturing Organization, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Contract Development and Manufacturing Organization, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Contract Development and Manufacturing Organization revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Contract Development and Manufacturing Organization market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Contract Development and Manufacturing Organization revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Contract Development and Manufacturing Organization Segment by Company

Catalent

Recipharm

Jubilant Life Sciences

Patheon Inc.

Boehringer Ingelheim

Pfizer Centreone

Aenova Group

Famar

Baxter Pharmaceutical Solutions

Lonza Group

Tesa Labtec

Tapemark

ARX LLC

Cambrex

Samsung Biologics

Fujifilm Diosynth Biotechnologies

WuXi Biologics

Center for Breakthrough Medicines (CBM)

Siegfried AG

Pharmaceutical Contract Development and Manufacturing Organization Segment by Type

API Development

Pharmaceutical Manufacturing

Pharmaceutical Contract Development and Manufacturing Organization Segment by Application

Large Enterprise

SME

Pharmaceutical Contract Development and Manufacturing Organization Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Development and Manufacturing Organization market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Development and Manufacturing Organization and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Development and Manufacturing Organization.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical Contract Development and Manufacturing Organization in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Contract Development and Manufacturing Organization company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Contract Development and Manufacturing Organization revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. API Development Major Player Table 3. Pharmaceutical Manufacturing Major Player Table 4. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Large Enterprise Major Player Table 6. SME Major Player Table 7. Pharmaceutical Contract Development and Manufacturing Organization Industry Trends Table 8. Pharmaceutical Contract Development and Manufacturing Organization Industry Drivers Table 9. Pharmaceutical Contract Development and Manufacturing Organization Industry Opportunities and Challenges Table 10. Pharmaceutical Contract Development and Manufacturing Organization Industry Restraints Table 11. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region (2021-2026) Table 14. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region (2027-2032) Table 16. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Players (2021-2026) Table 18. Global Pharmaceutical Contract Development and Manufacturing Organization Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Pharmaceutical Contract Development and Manufacturing Organization Key Players Headquarters & Area Served Table 20. Global Pharmaceutical Contract Development and Manufacturing Organization Players, Product Type & Application Table 21. Global Pharmaceutical Contract Development and Manufacturing Organization Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Pharmaceutical Contract Development and Manufacturing Organization by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Type (2021-2026) Table 28. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Type (2027-2032) Table 29. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application (2021-2026) Table 33. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application (2027-2032) Table 34. Catalent Company Information Table 35. Catalent Business Overview Table 36. Catalent Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Catalent Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 38. Catalent Recent Development Table 39. Recipharm Company Information Table 40. Recipharm Business Overview Table 41. Recipharm Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 43. Recipharm Recent Development Table 44. Jubilant Life Sciences Company Information Table 45. Jubilant Life Sciences Business Overview Table 46. Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 48. Jubilant Life Sciences Recent Development Table 49. Patheon Inc. Company Information Table 50. Patheon Inc. Business Overview Table 51. Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 53. Patheon Inc. Recent Development Table 54. Boehringer Ingelheim Company Information Table 55. Boehringer Ingelheim Business Overview Table 56. Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 58. Boehringer Ingelheim Recent Development Table 59. Pfizer Centreone Company Information Table 60. Pfizer Centreone Business Overview Table 61. Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 63. Pfizer Centreone Recent Development Table 64. Aenova Group Company Information Table 65. Aenova Group Business Overview Table 66. Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 68. Aenova Group Recent Development Table 69. Famar Company Information Table 70. Famar Business Overview Table 71. Famar Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Famar Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 73. Famar Recent Development Table 74. Baxter Pharmaceutical Solutions Company Information Table 75. Baxter Pharmaceutical Solutions Business Overview Table 76. Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 78. Baxter Pharmaceutical Solutions Recent Development Table 79. Lonza Group Company Information Table 80. Lonza Group Business Overview Table 81. Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 83. Lonza Group Recent Development Table 84. Tesa Labtec Company Information Table 85. Tesa Labtec Business Overview Table 86. Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 88. Tesa Labtec Recent Development Table 89. Tapemark Company Information Table 90. Tapemark Business Overview Table 91. Tapemark Pharmaceutical Contract Development and Manufacturing Organization Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 93. Tapemark Recent Development Table 94. ARX LLC Company Information Table 95. ARX LLC Business Overview Table 96. ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 98. ARX LLC Recent Development Table 99. Cambrex Company Information Table 100. Cambrex Business Overview Table 101. Cambrex Pharmaceutical Contract Development and Manufacturing Organization Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 103. Cambrex Recent Development Table 104. Samsung Biologics Company Information Table 105. Samsung Biologics Business Overview Table 106. Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 108. Samsung Biologics Recent Development Table 109. Fujifilm Diosynth Biotechnologies Company Information Table 110. Fujifilm Diosynth Biotechnologies Business Overview Table 111. Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 113. Fujifilm Diosynth Biotechnologies Recent Development Table 114. WuXi Biologics Company Information Table 115. WuXi Biologics Business Overview Table 116. WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 118. WuXi Biologics Recent Development Table 119. Center for Breakthrough Medicines (CBM) Company Information Table 120. Center for Breakthrough Medicines (CBM) Business Overview Table 121. Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 123. Center for Breakthrough Medicines (CBM) Recent Development Table 124. Siegfried AG Company Information Table 125. Siegfried AG Business Overview Table 126. Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 128. Siegfried AG Recent Development Table 129. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026) & (US$ Million) Table 130. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032) & (US$ Million) Table 131. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026) & (US$ Million) Table 132. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032) & (US$ Million) Table 133. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021-2026) & (US$ Million) Table 135. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (US$ Million) & (2027-2032) Table 136. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026) & (US$ Million) Table 139. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032) & (US$ Million) Table 140. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021-2026) & (US$ Million) Table 142. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (US$ Million) & (2027-2032) Table 143. China Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026) & (US$ Million) Table 144. China Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032) & (US$ Million) Table 145. China Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026) & (US$ Million) Table 146. China Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Region (US$ Million) & (2021-2026) Table 153. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Region (US$ Million) & (2027-2032) Table 154. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026) & (US$ Million) Table 157. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032) & (US$ Million) Table 158. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021-2026) & (US$ Million) Table 160. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (US$ Million) & (2027-2032) Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Pharmaceutical Contract Development and Manufacturing Organization Image Figure 2. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Share 2021 VS 2025 VS 2032 Figure 4. API Development Image Figure 5. Pharmaceutical Manufacturing Image Figure 6. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Share 2021 VS 2025 VS 2032 Figure 8. Large Enterprise Image Figure 9. SME Image Figure 10. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size (US$ Million) & (2021-2032) Figure 11. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Contract Development and Manufacturing Organization Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Type (2021-2032) Figure 18. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application (2021-2032) Figure 21. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2021-2032) Figure 23. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application (2021-2032) Figure 24. North America Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Country (2021-2032) Figure 25. United States Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2021-2032) Figure 30. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application (2021-2032) Figure 31. Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Country (2021-2032) Figure 32. Germany Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2021-2032) Figure 42. China Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application (2021-2032) Figure 43. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2021-2032) Figure 45. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application (2021-2032) Figure 46. Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Region (2021-2032) Figure 47. Japan Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2021-2032) Figure 55. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application (2021-2032) Figure 56. SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Country (2021-2032) Figure 57. Brazil Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Pharmaceutical Contract Development and Manufacturing Organization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • API Development
  • Pharmaceutical Manufacturing
Applications
  • Large Enterprise
  • SME
Companies covered
  • Catalent
  • Recipharm
  • Jubilant Life Sciences
  • Patheon Inc.
  • Boehringer Ingelheim
  • Pfizer Centreone
  • Aenova Group
  • Famar
  • Baxter Pharmaceutical Solutions
  • Lonza Group
  • Tesa Labtec
  • Tapemark
  • ARX LLC
  • Cambrex
  • Samsung Biologics
  • Fujifilm Diosynth Biotechnologies
  • WuXi Biologics
  • Center for Breakthrough Medicines (CBM)
  • Siegfried AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Contract Development and Manufacturing Organization Market by Type
  3. 1.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 API Development
  5. 1.2.3 Pharmaceutical Manufacturing
  6. 1.3 Pharmaceutical Contract Development and Manufacturing Organization Market by Application
  7. 1.3.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Large Enterprise
  9. 1.3.3 SME
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Pharmaceutical Contract Development and Manufacturing Organization Market Dynamics
  1. 2.1 Pharmaceutical Contract Development and Manufacturing Organization Industry Trends
  2. 2.2 Pharmaceutical Contract Development and Manufacturing Organization Industry Drivers
  3. 2.3 Pharmaceutical Contract Development and Manufacturing Organization Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Contract Development and Manufacturing Organization Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical Contract Development and Manufacturing Organization Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Players
  2. 4.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical Contract Development and Manufacturing Organization Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Contract Development and Manufacturing Organization Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical Contract Development and Manufacturing Organization Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical Contract Development and Manufacturing Organization Players, Product Type & Application
  8. 4.5 Global Pharmaceutical Contract Development and Manufacturing Organization Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical Contract Development and Manufacturing Organization Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Contract Development and Manufacturing Organization Market Size by Type
  1. 5.1 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application
  1. 6.1 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Catalent
  2. 7.1.1 Catalent Company Information
  3. 7.1.2 Catalent Business Overview
  4. 7.1.3 Catalent Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Catalent Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  6. 7.1.5 Catalent Recent Developments
  7. 7.2 Recipharm
  8. 7.2.1 Recipharm Company Information
  9. 7.2.2 Recipharm Business Overview
  10. 7.2.3 Recipharm Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  12. 7.2.5 Recipharm Recent Developments
  13. 7.3 Jubilant Life Sciences
  14. 7.3.1 Jubilant Life Sciences Company Information
  15. 7.3.2 Jubilant Life Sciences Business Overview
  16. 7.3.3 Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  18. 7.3.5 Jubilant Life Sciences Recent Developments
  19. 7.4 Patheon Inc.
  20. 7.4.1 Patheon Inc. Company Information
  21. 7.4.2 Patheon Inc. Business Overview
  22. 7.4.3 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  24. 7.4.5 Patheon Inc. Recent Developments
  25. 7.5 Boehringer Ingelheim
  26. 7.5.1 Boehringer Ingelheim Company Information
  27. 7.5.2 Boehringer Ingelheim Business Overview
  28. 7.5.3 Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  30. 7.5.5 Boehringer Ingelheim Recent Developments
  31. 7.6 Pfizer Centreone
  32. 7.6.1 Pfizer Centreone Company Information
  33. 7.6.2 Pfizer Centreone Business Overview
  34. 7.6.3 Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  36. 7.6.5 Pfizer Centreone Recent Developments
  37. 7.7 Aenova Group
  38. 7.7.1 Aenova Group Company Information
  39. 7.7.2 Aenova Group Business Overview
  40. 7.7.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  42. 7.7.5 Aenova Group Recent Developments
  43. 7.8 Famar
  44. 7.8.1 Famar Company Information
  45. 7.8.2 Famar Business Overview
  46. 7.8.3 Famar Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Famar Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  48. 7.8.5 Famar Recent Developments
  49. 7.9 Baxter Pharmaceutical Solutions
  50. 7.9.1 Baxter Pharmaceutical Solutions Company Information
  51. 7.9.2 Baxter Pharmaceutical Solutions Business Overview
  52. 7.9.3 Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  54. 7.9.5 Baxter Pharmaceutical Solutions Recent Developments
  55. 7.10 Lonza Group
  56. 7.10.1 Lonza Group Company Information
  57. 7.10.2 Lonza Group Business Overview
  58. 7.10.3 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  60. 7.10.5 Lonza Group Recent Developments
  61. 7.11 Tesa Labtec
  62. 7.11.1 Tesa Labtec Company Information
  63. 7.11.2 Tesa Labtec Business Overview
  64. 7.11.3 Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  66. 7.11.5 Tesa Labtec Recent Developments
  67. 7.12 Tapemark
  68. 7.12.1 Tapemark Company Information
  69. 7.12.2 Tapemark Business Overview
  70. 7.12.3 Tapemark Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  72. 7.12.5 Tapemark Recent Developments
  73. 7.13 ARX LLC
  74. 7.13.1 ARX LLC Company Information
  75. 7.13.2 ARX LLC Business Overview
  76. 7.13.3 ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  77. 7.13.4 ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  78. 7.13.5 ARX LLC Recent Developments
  79. 7.14 Cambrex
  80. 7.14.1 Cambrex Company Information
  81. 7.14.2 Cambrex Business Overview
  82. 7.14.3 Cambrex Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  84. 7.14.5 Cambrex Recent Developments
  85. 7.15 Samsung Biologics
  86. 7.15.1 Samsung Biologics Company Information
  87. 7.15.2 Samsung Biologics Business Overview
  88. 7.15.3 Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  90. 7.15.5 Samsung Biologics Recent Developments
  91. 7.16 Fujifilm Diosynth Biotechnologies
  92. 7.16.1 Fujifilm Diosynth Biotechnologies Company Information
  93. 7.16.2 Fujifilm Diosynth Biotechnologies Business Overview
  94. 7.16.3 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  96. 7.16.5 Fujifilm Diosynth Biotechnologies Recent Developments
  97. 7.17 WuXi Biologics
  98. 7.17.1 WuXi Biologics Company Information
  99. 7.17.2 WuXi Biologics Business Overview
  100. 7.17.3 WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  101. 7.17.4 WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  102. 7.17.5 WuXi Biologics Recent Developments
  103. 7.18 Center for Breakthrough Medicines (CBM)
  104. 7.18.1 Center for Breakthrough Medicines (CBM) Company Information
  105. 7.18.2 Center for Breakthrough Medicines (CBM) Business Overview
  106. 7.18.3 Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  108. 7.18.5 Center for Breakthrough Medicines (CBM) Recent Developments
  109. 7.19 Siegfried AG
  110. 7.19.1 Siegfried AG Company Information
  111. 7.19.2 Siegfried AG Business Overview
  112. 7.19.3 Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  114. 7.19.5 Siegfried AG Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country
  11. 8.6.1 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country
  11. 9.6.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical Contract Development and Manufacturing Organization Revenue (2021-2032)
  2. 10.2 China Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country
  11. 11.6.1 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical Contract Development and Manufacturing Organization Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst